FI971193L - Hoidossa käyttökelpoisia kinoksaliinijohdannaisia - Google Patents

Hoidossa käyttökelpoisia kinoksaliinijohdannaisia Download PDF

Info

Publication number
FI971193L
FI971193L FI971193A FI971193A FI971193L FI 971193 L FI971193 L FI 971193L FI 971193 A FI971193 A FI 971193A FI 971193 A FI971193 A FI 971193A FI 971193 L FI971193 L FI 971193L
Authority
FI
Finland
Prior art keywords
therapy
derivatives useful
quinoxaline derivatives
quinoxaline
useful
Prior art date
Application number
FI971193A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971193A7 (fi
FI971193A0 (fi
Inventor
Michael Jonathan Fray
Charles Eric Mowbray
Alan Stobie
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of FI971193A0 publication Critical patent/FI971193A0/fi
Publication of FI971193A7 publication Critical patent/FI971193A7/fi
Publication of FI971193L publication Critical patent/FI971193L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI971193A 1994-09-24 1995-09-08 Hoidossa käyttökelpoisia kinoksaliinijohdannaisia FI971193L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419318A GB9419318D0 (en) 1994-09-24 1994-09-24 Therapeutic agents
PCT/EP1995/003559 WO1996009295A1 (en) 1994-09-24 1995-09-08 Quinoxaline derivatives useful in therapy

Publications (3)

Publication Number Publication Date
FI971193A0 FI971193A0 (fi) 1997-03-21
FI971193A7 FI971193A7 (fi) 1997-05-21
FI971193L true FI971193L (fi) 1997-05-21

Family

ID=10761869

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971193A FI971193L (fi) 1994-09-24 1995-09-08 Hoidossa käyttökelpoisia kinoksaliinijohdannaisia

Country Status (28)

Country Link
US (1) US5852016A (cs)
EP (1) EP0783495B1 (cs)
JP (1) JP2986920B2 (cs)
KR (1) KR970706261A (cs)
CN (1) CN1158610A (cs)
AT (1) ATE213731T1 (cs)
AU (1) AU688591B2 (cs)
BR (1) BR9504132A (cs)
CA (1) CA2200742C (cs)
CO (1) CO4410336A1 (cs)
CZ (1) CZ85797A3 (cs)
DE (1) DE69525633T2 (cs)
DK (1) DK0783495T3 (cs)
ES (1) ES2171553T3 (cs)
FI (1) FI971193L (cs)
GB (1) GB9419318D0 (cs)
HU (1) HUT77734A (cs)
IL (2) IL115334A0 (cs)
MX (1) MX9702259A (cs)
NO (1) NO971261L (cs)
NZ (1) NZ292922A (cs)
PE (1) PE47596A1 (cs)
PL (1) PL319405A1 (cs)
PT (1) PT783495E (cs)
RU (1) RU2135484C1 (cs)
TR (1) TR199501158A2 (cs)
WO (1) WO1996009295A1 (cs)
ZA (1) ZA958023B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
ES2168119T3 (es) * 1995-10-10 2002-06-01 Pfizer Derivados de quinoxalina para el tratamiento de tinnitus.
GB9604400D0 (en) 1996-03-01 1996-05-01 Pfizer Ltd Compounds useful in therapy
WO1997046539A1 (en) * 1996-06-05 1997-12-11 Warner-Lambert Company Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
US5922715A (en) * 1997-02-18 1999-07-13 American Home Products Corporation 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones
CA2278757A1 (en) * 1997-02-18 1998-08-20 Uresh Shantilal Shah 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
CA2419301C (en) * 2000-08-21 2009-12-08 Astrazeneca Ab Quinazoline derivatives
GB0310881D0 (en) * 2003-05-12 2003-06-18 Merck Sharp & Dohme Pharmaceutical formulation
RU2251546C1 (ru) * 2003-08-29 2005-05-10 ООО "Исследовательский институт химического разнообразия" Замещенные 3-оксо-1,2,3,4-тетрагидрохиноксалины, фармацевтические композиции (варианты), способ их получения и применения
US10208000B2 (en) 2015-12-16 2019-02-19 University Of Kentucky Research Foundation Eis inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE572852C (de) * 1931-03-08 1933-03-24 Willy Messerschmitt Dipl Ing Verfahren zur Herstellung von Flugzeugtragfluegeln mit trapezfoermigem Grundriss
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
ATE194985T1 (de) * 1990-11-06 2000-08-15 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
DE4123106A1 (de) * 1991-07-09 1993-01-14 Schering Ag Arzneimittel zur behandlung von entzugssymptomen
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
KR100304017B1 (ko) * 1992-06-22 2001-11-22 추후제출 글리신수용체길항물질및이의용도
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE4439493A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5614508A (en) * 1995-06-07 1997-03-25 Warner-Lambert Company Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists

Also Published As

Publication number Publication date
FI971193A7 (fi) 1997-05-21
IL126104A0 (en) 1999-05-09
CA2200742A1 (en) 1996-03-28
GB9419318D0 (en) 1994-11-09
CO4410336A1 (es) 1997-01-09
AU688591B2 (en) 1998-03-12
EP0783495B1 (en) 2002-02-27
JP2986920B2 (ja) 1999-12-06
MX9702259A (es) 1997-06-28
KR970706261A (ko) 1997-11-03
PE47596A1 (es) 1996-11-12
NZ292922A (en) 1998-07-28
JPH09511526A (ja) 1997-11-18
TR199501158A2 (tr) 1997-02-21
US5852016A (en) 1998-12-22
IL115334A0 (en) 1995-12-31
AU3523295A (en) 1996-04-09
NO971261L (no) 1997-05-05
CA2200742C (en) 2001-09-11
CN1158610A (zh) 1997-09-03
HUT77734A (hu) 1998-07-28
ES2171553T3 (es) 2002-09-16
WO1996009295A1 (en) 1996-03-28
ATE213731T1 (de) 2002-03-15
ZA958023B (en) 1997-03-24
EP0783495A1 (en) 1997-07-16
PT783495E (pt) 2002-07-31
RU2135484C1 (ru) 1999-08-27
NO971261D0 (no) 1997-03-19
DE69525633T2 (de) 2002-08-08
CZ85797A3 (cs) 1998-09-16
PL319405A1 (en) 1997-08-04
DE69525633D1 (de) 2002-04-04
DK0783495T3 (da) 2002-04-22
FI971193A0 (fi) 1997-03-21
BR9504132A (pt) 1996-08-06

Similar Documents

Publication Publication Date Title
FI970762L (fi) Terapiassa käyttökelpoiset spiroatsabisykliset yhdisteet
NO983560D0 (no) Triazolderivater nyttige i terapi
FI954681A7 (fi) Sykloalkano-indoli- ja azaindolijohdannaisia
FI954829L (fi) Aroyylipiperidiinijohdannaiset
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
FI971227L (fi) Pyramidinyylipyratsolijohdannaisia
FI971193A7 (fi) Hoidossa käyttökelpoisia kinoksaliinijohdannaisia
FI964267A7 (fi) Porfosyaniini ja CNC-laajennetut porfyriinit
DE69527786D1 (de) Diaminomethyliden-derivate
FI964853A7 (fi) Deasetoksitaksolijohdannaiset
FI961339L (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
DE69510792D1 (de) Naphtochinonderivate
DE59509209D1 (de) Diphenyloxazolin-derivate
FI955026L (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
FI960464A0 (fi) Piirikokoonpano
FI963122L (fi) Karbamoyylimetyyliureajohdannaiset
KR960016750U (ko) 캐스터
KR950024525U (ko) 침관
FI1691U1 (fi) Hopsaettningsmaskin foer lastpallsben
SE9602645D0 (sv) Azabicyclic derivatives useful in therapy
FI1916U1 (fi) Anordning foer reglering av cirkelsaogsklingors in boerdes avstaond
KR960020800U (ko) 캐스터
KR960004028U (ko) 쑥뜸 구